Mete Civelek

14.8k citations
85 papers · 4.5k indexed · 2 hit papers · h-index 35

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Immunology top 2%
    • Atherosclerosis and Cardiovascular Diseases
    • Phagocytosis and Immune Regulation

Papers in

    • Cancer-related molecular mechanisms research 10
    • Genetic Associations and Epidemiology 15

Mete Civelek

80 papers receiving 4.5k citations

Hit Papers

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis 2016 · 500 citations
5002013202620172021100200300400500

Peers

Mete Civelek
Comparison fields: 5 of 133
  • Cancer Research 854
  • Immunology 997
  • Molecular Biology 2.6k
  • Physiology 677
  • Genetics 703
Replace Masahide Ohmichi with:
Masahide Ohmichi Japan
Matthias Szabolcs United States
Hyun Kook South Korea
Hirohisa Kurachi Japan
Uwe Knippschild Germany
Roméo Ricci France
Kirk M. Druey United States
Jack Pollard United States
Karol Bomsztyk United States
Jianxin Sun United States
Mete Civelek relative to Masahide Ohmichi Japan Masahide Ohmichi's profile →
Citations per field
00.5×1.5×2.5×
Masahide Ohmichi · 1×
Citations per year

Countries citing papers authored by Mete Civelek

Since Specialization
Citations

This map shows the geographic impact of Mete Civelek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mete Civelek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mete Civelek more than expected).

Fields of papers citing papers by Mete Civelek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mete Civelek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mete Civelek. The network helps show where Mete Civelek may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mete Civelek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mete Civelek Line = papers co-authored together Mete Civelek links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 202411
4 20242
5 20246
6 20234
7 202116
8 202173
9 202124
10 20207
11 20205
12 201964
13 201851
14 201879
15 2017133
16 201723
17 201361
18 2012203
19 2010365
20 2009181

About Mete Civelek

Mete Civelek is a scholar working on Cancer Research, Genetics, Immunology, Molecular Biology and Physiology, having authored 85 papers that have together received 4.5k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (16 papers), Genetic Associations and Epidemiology (15 papers), Adipose Tissue and Metabolism (14 papers), Bioinformatics and Genomic Networks (12 papers), Peroxisome Proliferator-Activated Receptors (11 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers) and RNA Research and Splicing (6 papers). The work is most often cited by research in Cancer Research (854 citations), Immunology (997 citations), Molecular Biology (2.6k citations), Physiology (677 citations) and Genetics (703 citations). Mete Civelek has collaborated with scholars based in United States, Finland and Sweden. Frequent co-authors include Aldons J. Lusis, Peter F. Davies, Yun Fang, Elisabetta Manduchi, Congzhu Shi, Ingrid Fleming, Christian J. Stoeckert, Rebecca Riley, Clint L. Miller and Eric E. Schadt. Their work appears in journals such as Circulation Research, Diabetes, PLoS Genetics, Scientific Reports and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026